According to Dr Opas Karnkawinpong, director-general of the Department ofDisease Control (DDC), 7,000 of the ordered 257,500 doses will be delivered onJuly 25.
The DDC director-general said the drug would initially be prescribed toorgan-transplant recipients and patients with chronic kidney disease whorequire dialysis, immunosuppressants. He added that one dose of Evusheld shouldprovide six months of immunity against COVID-19.
Evusheld will also be administered to patients over the age of 12 who areunderweight or have not received their COVID vaccinations.
The Ministry of Public Health opted to purchase 257,500 doses of Evusheld fromAstraZeneca and reduce its vaccine order with the drugmaker from 60 million to35.4 million doses. The medication is expected to be distributed to state-runhospitals nationwide.
According to the U.S. Food and Drug Administration (FDA), Evusheld is anintramuscular injection containing two long-acting antibodies. The U.S. agencyadvises healthcare providers to administer Evusheld only to individuals who arenot currently infected with the novel coronavirus or SARS-CoV-2 and have nothad a known recent exposure to a carrier of the virus./.